These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA). Lum CT; Sutherland DE; Foker JE; Najarian JS Surg Forum; 1977; 28():320-2. PubMed ID: 364724 [No Abstract] [Full Text] [Related]
45. Studies on the effects of infusion of enzyme inhibitors on mouse adenosine deaminase. Trotta PP; Ahland MP; Brown GF; Balis ME Mol Pharmacol; 1978 Jan; 14(1):199-209. PubMed ID: 625284 [No Abstract] [Full Text] [Related]
46. Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3. Suling WJ; Rice LS; Shannon WM Cancer Treat Rep; 1978 Mar; 62(3):369-73. PubMed ID: 647695 [No Abstract] [Full Text] [Related]
48. Inhibitors of adenosine deaminase and the development of antiviral agents. Cohen SS Ann N Y Acad Sci; 1985; 451():204-14. PubMed ID: 2416257 [No Abstract] [Full Text] [Related]